lestaurtinib has been researched along with 5'-iodoindirubin in 1 studies
| Studies (lestaurtinib) | Trials (lestaurtinib) | Recent Studies (post-2010) (lestaurtinib) | Studies (5'-iodoindirubin) | Trials (5'-iodoindirubin) | Recent Studies (post-2010) (5'-iodoindirubin) |
|---|---|---|---|---|---|
| 124 | 12 | 63 | 6 | 0 | 1 |
| Protein | Taxonomy | lestaurtinib (IC50) | 5'-iodoindirubin (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase 17B | Homo sapiens (human) | 6.2 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 4.722 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SJ; Choi, SU; Han, SY; Kim, YC; Lee, SD; Moon, MJ | 1 |
1 other study(ies) available for lestaurtinib and 5'-iodoindirubin
| Article | Year |
|---|---|
Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Leukemia, Myeloid, Acute | 2010 |